AstraZeneca Pharma rises 4% on getting CDSCO nod to import cancer treatment drug
- Hot Stocks
admin
- 0
- 1 minute read
AstraZeneca Pharma stock has risen 57 percent in the last one year, outperforming benchmark Nifty 50 which has risen 30 percent during the same period.
:max_bytes(150000):strip_icc():format(jpeg)/PropertyValuation-4ecdfe3a87144fe998087ef433f49c13.jpeg "Is There a Gender Gap in Home Equity Loans?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1917868586-d64880817bca4098bc8be36bbd17a4e9.jpg "Should You Trade Options on Spot Bitcoin ETFs?")